Clinical Trials Directory

Trials / Completed

CompletedNCT03165279

ZEnith AlPHa for AneurYsm Repair

ZEnith AlPHa for AneurYsm Repair (ZEPHYR)

Status
Completed
Phase
Study type
Observational
Enrollment
354 (actual)
Sponsor
Philippe Cuypers · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To prospectively collect 'real world' performance data on the Zenith AlphaTM Abdominal Endovascular Graft for endovascular aneurysm repair, inside and outside instructions for use. To assess clinical efficacy of the low-profile device to treat patients with abdominal aortic aneurysm (AAA), to assess the use of the new delivery and deployment system of the Zenith AlphaTM Abdominal Endovascular Graft. Primary endpoint is the proportion of subjects who experience successful treatment at 1 year post-implant; defined by technical success and clinical success.

Detailed description

The ZEPHYR registry has two major objectives: 1. to prospectively collect 'real world' safety, durability and clinical performance data on the Zenith AlphaTM Abdominal Endovascular Graft in subjects with infrarenal abdominal aortic or aorto-iliac aneurysms. 2. To increase the clinical evidence about the safety and effectiveness of the Zenith AlphaTM Abdominal Endovascular Graft by creating a database that can be pooled and/or compared with databases available on this and other stent graft systems. The ZEPHYR registry is a multi-center, post-market, non-randomized, single-arm prospective study. The study has no controls, as it is descriptive in nature. It will recruit approximately 450 subjects from high-volume sites across Germany and the BeNeLux. Study is open to consecutively enrolled subjects (20-50 per site) whou in the opinion of the investigator are candidates for endovascular AAA repair. The sites are recommended to schedule the subject's post-operative follow-up visits based on the current standard care in endovascular aneurysm repair (EVAR) therapy, which is generally at 1 month, 1 year and annually thereafter.

Conditions

Interventions

TypeNameDescription
PROCEDUREZenith Alpha Abdominal stentgraft

Timeline

Start date
2016-12-07
Primary completion
2022-05-01
Completion
2022-07-01
First posted
2017-05-24
Last updated
2022-07-20

Locations

12 sites across 3 countries: Belgium, Germany, Netherlands

Source: ClinicalTrials.gov record NCT03165279. Inclusion in this directory is not an endorsement.